Cancer-fighting bacterial product ‘cocktails’ may offer personalized treatment
Peer-Reviewed Publication
Updates every hour. Last Updated: 22-Jan-2026 00:11 ET (22-Jan-2026 05:11 GMT/UTC)
Three recently published studies by Medical University of South Carolina researchers each adopted a unique approach to improving our understanding of hypermobile Ehlers-Danlos Syndrome (hEDS), one taking a clinical, one a genetic and the most recent a proteomics approach. All three studies suggested a potential immune component for the disease, challenging long-held assumptions that hEDS is primarily a connective tissue disease. This new conceptualization of the disease better reflects the lived experience of patients.